Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124658603 | 12465860 | 3 | F | 20160530 | 20160721 | 20160614 | 20160802 | EXP | CA-ACTELION-A-NJ2016-137257 | ACTELION | 55.00 | YR | A | F | Y | 38.95000 | KG | 20160802 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124658603 | 12465860 | 1 | PS | Caripul | EPOPROSTENOL | 1 | Intravenous (not otherwise specified) | UNK | U | 22260 | INJECTION | ||||||||
| 124658603 | 12465860 | 2 | SS | TRACLEER | BOSENTAN | 1 | Oral | 62.5 MG, BID | U | U | 21290 | 62.5 | MG | TABLET | BID | ||||
| 124658603 | 12465860 | 3 | C | OXYGEN. | OXYGEN | 1 | 8 L/MIN WHILE SLEEPING, 4 L/MIN AT REST | U | 0 | ||||||||||
| 124658603 | 12465860 | 4 | C | WARFARIN | WARFARIN | 1 | 1 MG, UNK | U | 0 | 1 | MG | ||||||||
| 124658603 | 12465860 | 5 | C | WARFARIN | WARFARIN | 1 | 2 MG, UNK | U | 0 | 2 | MG | ||||||||
| 124658603 | 12465860 | 6 | C | VENTOLIN | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | UNK PUFF, UNK | U | 0 | |||||||||
| 124658603 | 12465860 | 7 | C | NOVO-FERROGLUC | 2 | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||||
| 124658603 | 12465860 | 8 | C | RANITIDINE. | RANITIDINE | 1 | 150 UNK, BID | U | 0 | BID | |||||||||
| 124658603 | 12465860 | 9 | C | SLOW K | POTASSIUM CHLORIDE | 1 | 1200 MG, BID | U | 0 | 1200 | MG | BID | |||||||
| 124658603 | 12465860 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 80 MG, BID | U | 0 | 80 | MG | BID | |||||||
| 124658603 | 12465860 | 11 | C | ATIVAN | LORAZEPAM | 1 | 0.5 MG,TID PRN | U | 0 | .5 | MG | TID | |||||||
| 124658603 | 12465860 | 12 | C | SANDOZ-MIRTAZAPINE | 2 | 15 MG HALF A TABLET HS | U | 0 | 15 | MG | |||||||||
| 124658603 | 12465860 | 13 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0.125 MG, QD | U | 0 | .125 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124658603 | 12465860 | 1 | Pulmonary arterial hypertension |
| 124658603 | 12465860 | 2 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124658603 | 12465860 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124658603 | 12465860 | Catheter site inflammation | |
| 124658603 | 12465860 | Dyspnoea exertional | |
| 124658603 | 12465860 | Headache | |
| 124658603 | 12465860 | Lung infection | |
| 124658603 | 12465860 | Pneumonia | |
| 124658603 | 12465860 | Road traffic accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124658603 | 12465860 | 1 | 20141014 | 0 |